Nutritional and Plasma Antioxidant Status Assessment in a Group of Old Alzheimer&#8217;s Inpatients by G. Turconi et al.
Volume 1 • Issue 1 • 1000101
J Nutr Food Sci
ISSN: 2155-9600 JNFS, an open access journal
Open AccessResearch Article
Nutrition & Food
Sciences
Turconi et al. J Nutr Food Sci 2011, 1:1
http://dx.doi.org/10.4172/2155-9600.1000101
Keywords: Alzheimer’s disease; Nutritional assessment; MNA; 
MMSE; Antioxidant plasma levels
Introduction
Oxidative stress has been implicated in mechanisms leading 
to neuronal cell injury in various pathological states of the brain. 
Accumulated damage to lipid membranes and DNA by oxygen free 
radicals and reactive oxygen species is thought to disrupt normal cell 
functioning and lead to neuronal death. Alzheimer’s disease (AD) is 
a progressive disorder with cognitive and memory decline, speech 
loss, personality changes and synapse loss. Many studies suggest that 
oxidative damage is one of the factors in the neuronal death underlying 
the loss of cognition [1-4].
Antioxidant nutrients, including vitamin E, vitamin C, and 
carotenoids, are among the body’s natural defense mechanisms against 
oxidative stress [5-8]. The antioxidant nutrients have been shown 
through animal and laboratory studies of brain tissue to decrease lipid 
peroxidation [9,10], and the oxidation of proteins [11,12], inhibit the 
production of reactive oxygen species [13], prevent mitochondrial 
dysfunction [14] and DNA fragmentation [15], and reduce 
neurotoxicity [16,17], apoptosis [18], and neuronal death [19].
The results of some large community studies, Eva study [20] and 
the Chicago Health and Aging Project [21], demonstrated that the 
increased levels of oxidative stress [22] and/or antioxidant deficiencies 
may pose risk factors for cognitive decline, even when controlled for 
nutritional status.
Consequently, the effects of intake of antioxidant nutrients and 
flavonoids, in the prevention of cognitive impairment and dementia, 
have been widely investigated [23-27].
Given this background, assessment of nutritional biomarkers 
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Abstract
This study was carried out to assess the nutritional and plasma antioxidant status of Alzheimer’s inpatients 
compared to age-matched controls by means of anthropometric measurements, neuropsychological and nutritional 
tests and plasma biomarkers. Assessment of nutritional biomarkers of prooxidant/antioxidant balance in patients 
with AD as well as nutritional status and neuropsychological evaluation are important since many studies have 
demonstrated their association with cognitive impairment.
This cross sectional study was carried out in 35 subjects recruited in a geriatric institution in Pavia, Northern Italy. 
Cases mean Body Mass Index (BMI) was lower than controls’ one as well as mid arm circumference, triceps 
skinfold and arm muscle circumference. Both inpatients MNA and MMSE mean scores were lower than controls 
ones. Plasma levels of lutein plus zeaxanthin, beta-cryptoxanthin, lycopene, alfa tocopherol, ascorbic acid were 
significantly lower (p < 0.05) in AD in patients as well as superoxide desmutase and glutathione peroxidase 
concentrations, while all the other biochemical markers levels did not differ.
Plasma antioxidant levels and activities were decreased in AD and could be biologically predictive of an early 
mild cognitive decline, suggesting early intervention on dietary antioxidant intake.
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of prooxidant/antioxidant balance in patients with AD is important 
since the many studies above described have demonstrated the 
association between cognitive impairment and antioxidant status in 
this population.
Besides nutritional status in older adults is an issue of increasing 
importance, especially in demented patients, at risk of malnutrition. 
In the elderly, chronic co-morbidities are more difficult to treat for 
the potentially bad nutritional conditions. Malnutrition is a condition 
associated with functional and cognitive decline in the demented 
elderly.
The aim of this study was to assess the nutritional and plasma 
antioxidant status of old Alzheimer’s inpatients compared to age-
matched controls by means of anthropometric measurements, 
neuropsychological and nutritional tests and the evaluation of the 
following biomarkers plasma levels: GSH levels (total and oxidized), 
glutathione peroxidase, superoxide desmutase, ascorbic acid, retinol, 
alfa tocopherol, lutein plus zeaxanthin, beta-cryptoxanthin, alpha-
carotene, beta-carotene, lycopene.
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Material and Methods
Sampling
Twenty-one subjects with AD (5 males and 16 females) and 14 
controls (4 males and 10 females), aged 65-92 years, have been recruited 
at Santa Margherita Hospital in Pavia, Italy, a geriatric institution. All 
the 21 inpatients affected by AD, once diagnosed, had been hospitalized 
since October- December 2007, while the controls were outpatients in 
good health. 
Diagnosis of AD was made according to criteria of the National 
Institute of Neurological and Communicative Disorders and Stroke 
and Alzheimer’s disease and Related Dementia Association (NINCDS-
ADRDA) [28].
A brief interview was conducted with inpatients’ relatives as well as 
with all the outpatients to assess familiarity for AD.
The research protocol was approved by both the Ethics Committee 
of the Faculty of Medicine of the University of Pavia and the Ethics 
Committee of the Geriatric Institution.
Informed written consent was obtained from each outpatient and 
from the inpatients’ relatives.
Anthropometric measurements
•	 All the subjects had been examined by health personnel (medical 
doctors and dietitians) and the following parameters weWeight, 
measured on subjects wearing only underwear and without shoes 
by means of a steelyard scale;
•	 Stature, estimated by knee height measurement;
•	 Mid-triceps skin folds thickness measured on subjects according to 
standard conditions using a Harpenden skin fold thickness calliper; 
three consecutive measurements were performed and the mean of 
the three values was considered;
•	 Mid arm circumference, measured on subjects according to 
standard conditions using a measuring tape.
BMI was calculated as a ratio between weight and height squared 
with weight in kilograms and height in meters while arm muscle 
circumference was computed according to standard equation of 
Frisancho [29].
Neuropsychological and nutritional tests
The Mini-Mental State Examination (MMSE) [30], the most 
commonly used mental status test with the elderly, has been performed 
on all 35 subjects as well as the Mini Nutritional Assessment (MNA) 
[31] in order to assess nutritional status of the enrolled subjects.
Biochemical measurements 
Chemicals: Ascorbic acid, formic acid, retinol, α-tocopherol, 
lutein, β-carotene and lycopene were from Sigma Chemical. Other 
carotenoids and echinenone were from F. Hoffmann-La Roche & Co., 
Basel, Switzerland
Biochemical analysis
Carotenoids, retinol and tocopherol determination in plasma: 
Blood samples were collected in tubes containing lithium-heparin and 
centrifuged at 1000 x g for 10 min to obtain plasma and red blood cells. 
After separation, 100 L of ethanol containing echinenone as internal 
standard were added to 100µL plasma. The samples were immediately 
vortexed therefore 250µL of hexane were added for analytes extraction. 
Samples were vortexed again for 1 min and centrifuged at 1000 x g 
for 5 min, supernatant (200µL) was recovered, evaporated under N2 
atmosphere and stored at -80°C until analysis. For HPLC separation 
samples were dissolved in 100 µL of methanol-tetrahydrofuran 
(MetOH: THF, 90:10) immediately before analysis. 
The chromatographic system (HPLC) used for separation and 
quantification of carotenoids and vitamins consisted of an Alliance 
model 2695 (Waters, Milford, MA, USA) equipped with a model 
2996 (Waters) photodiode array detector. All data were acquired by 
Empower 2 Chromatography Data Software (Waters) [32]. 
A 5 mm Vydac 201TP54 C18 column (250 x 4.6 mm; Vidac, 
Esperia, CA, USA) fitted with a C18 guard column and biocompatible 
frits was used for the separation of carotenoids, retinol and -tocopherol 
which was performed by means of a linear gradient elution (eluent A, 
methanol; eluent B, THF) at a flow rate of 1.2 ml/min. The gradient was 
as follows: from 100 to 95% A in 5 min, from 95 to 85% A in 15 min and 
then from 85 to 100% A in 10 min.
Chromatographic data were acquired in the 200–600 nm range 
and were integrated at 445 nm for lutein, zeaxanthin, β-cryptoxanthin, 
echinenone and α- and β-carotene (Figure 1), at 472 nm for lycopene, 
at 325 nm for retinol and at 292 nm for tocopherol.
Carotenoids concentrations were calculated by means of a mix of 
standards in the range 0.1-1.0 µg/ml containing lutein, zeaxanthin, 
β-cryptoxanthin α-carotene and β-carotene while lycopene was 
prepared daily (to avoid degradation) and injected separately. Data 
were corrected by recovery of the internal standard. Retinol and 
tocopherol were quantified by calibration curves obtained daily before 
sample analysis by injecting increasing amounts of the standards 
(dissolved in ethanol) in the range 0.5–5 µg/ml (retinol) and 2–20 µg/
ml (tocopherol).
Ascorbic acid determination in plasma: Immediately after blood 
centrifugation plasma was separated and acidified using an equal 
volume of metaphosphoric acid (MPA) 10% (w/v) solution (100µL 
plasma + 100µL MPA). Samples were stored at -80°C for 7 days. 
At the time of determination the samples were vortexed and 
centrifuged at 2000 x g for 1 min, and 50µL of the supernatant were 
immediately injected for HPLC analysis. 
The chromatographic system is the same of that above-mentioned 
and the chromatographic data were acquired at 245 nm. 
Figure 1: Typical HPLC chromatogram at 445 nm of plasma sample.
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A 5 mm Atlantis C18 column (250 x 4.6 mm; Waters) fitted with 
a C18 guard column was used for the separation of ascorbic acid and 
the flow rate was fixed to 1.4 ml/min. The eluent was formic acid 0.1%. 
Ascorbic acid standard solutions were prepared daily by dissolving 
standard power in MPA 10% to obtain calibration curves in a range of 
concentrations of 2.5-20 µg/ml.
Erythrocytes enzymes activity determination: Erythrocytes 
lysate were prepared according to kit indications (Cayman Chemical 
Company, Ann Arbor, MI, USA). Briefly, blood was centrifuged at 1000 
x g for 10 min at 4°C, than plasma and buffy layer were removed and 
erythrocytes were lysed by adding 4 volumes of ice-cold HPLC grade 
water. Samples were centrifuged at 10000 x g for 15 min at 4°C and 
supernatant was aliquoted in vials and stored at -80°C until analysis. 
Superoxide dismutase, glutathione peroxidase activities and GSH 
levels (total and oxidized) were measured by means Cayman kits (cod. 
706002, cod. 703102 and cod. 703002 respectively) and by using a 
plate reader at 450nm, 340nm and 405nm respectively. Results were 
expressed in U/mg Hb for SOD activity, mU/g Hb for GSH-Px and 
µmol/g Hb for GSH and GSSG.
Statistical analysis
The data analyses were performed using the Statistical Package 
for the Social Science/PC version 10, Chicago- SPSS Inc. T-student 
test was used to compare results between the two groups of elderly. 
Multiple regression analysis was carried out to verify the impact of 
the anthropometric and biochemical measurements on MNA and on 
MMSE respectively. 
Results
Sample characteristics (Mean ± Standard Deviation) are reported 
in Table 1. All the variables were statistically different, except age. 
All the inpatients had good deambulation although not self 
sufficient, 13 and 8 of them had good or moderate chewing ability 
respectively; 16 and 5 of them had a moderate or good visus respectively. 
Six of them had one or more relatives with AD. 
All the controls had good deambulation and were self sufficient, 
with good chewing ability; 12 and 2 of them had a good or moderate 
visus respectively. All the controls were in good health, 64% of 
them suffer from hypertension, diabetes and asthma, but were 
pharmacologically well compensated. Cases mean BMI was lower than 
controls’ one as well as mid arm circumference, triceps skinfold and 
arm muscle circumference.
Thirteen cases were normal weight according to BMI, 6 were 
overweight and 2 were underweight, while 5 controls were normal 
weight, 7 were overweight and 2 were obese.
Mean mid arm circumference of the cases was below the 5th 
percentile while the controls’ one was between the 25th and 50th 
percentiles [33].
The triceps skinfolds of the cases were below the 25th percentile in 
all the females (6 between the 10th and 25th percentiles and 5 below the 
5th percentile) and between the 25th and 50th percentiles in all the males 
(cases and controls) while 4 control females were between the 5th and 
10th percentiles and 6 were between the 50th and 75th percentiles [33].
As far as arm muscle circumference concerns 6 cases were below 
the 5th percentile, 2 were between the 5th and 10th percentiles, 7 were 
between the 10th and 25th percentiles and 6 over the 25th percentile.
On the other hand none of the controls set below the 10th 
percentile, 8 were between the 10th and 25th percentiles and 6 over the 
50th percentile [33].
Both inpatients MNA and MMSE mean scores were lower than 
controls ones. 
All the controls were well nourished, with MNA scores more than 
24, while 15 cases were at risk of energy-protein malnutrition (MNA 
between 17 and 23,5) and 6 AD patients were severely malnourished 
(MNA < 17) [31].
All the controls scored MMSE more than 24, while 19 cases scored 
between 10 and 24 (moderate AD) and 2 scored less than 10 (severe 
AD) [30].
MMSE and MNA in the total sample were significantly correlated 
(R= 0.72; p<0.01).
Multiple regression analysis carried out to verify the impact of 
the two circumferences (mid arm circumference and arm muscle 
circumference), the triceps skinfolds, BMI and MNA on MMSE in the 
total sample, showed that MNA is the most closely and significantly 
correlated (R= 0.70; P< 0.001). 
Biochemical markers values (Mean Standard Deviation) are 
reported in Table 2.
Plasma levels of lutein plus zeaxanthin, beta-cryptoxanthin, 
lycopene, alfa tocopherol, ascorbic acid were significantly lower (p < 
0.05) in AD inpatients. 
Superoxide desmutase and glutathione peroxidase concentrations 
were significantly lower (p < 0.05) in AD inpatients too.
All the other biochemical markers levels did not differ between 
cases and controls.
Variables Cases (n=21) Controls (n=14) T-Test
mean S.D. mean S.D. p value
Age (yrs)  81.5 5.5 78.8 3.2 0.1072
BMI (kg/m2) 23.2 3.1 26.5 4.7 < 0.01
Mid Arm Circumference (cm) 24.4 3.6 28.6 3.2 < 0.001
Triceps Skinfold (mm) 11.1 4.9 17.7 6.8 < 0.002
Arm Muscle Circumference (cm) 20.9 2.6 23.1 3.0 < 0.05
MNA* score 18.5 4.0 27.6 1.2 < 0.0001
MMSE† score 18.4 5.9 29.2 0.8 < 0.0001
*Mini Nutritional Assessment test; †Mini-Mental State Examination test
Table 1: Sample characteristics.
Biomarkers Cases(n=21)
Controls
(n= 14)
T-Test 
mean S.D. mean S.D. p value
Total GSH (μmol/g Hb) 7.16 1.48 6.71 1.30 0.369
GSSG (μmol/g Hb) 0.64 0.21 0.63 0.15 0.837
GPx (U/g Hb) 15.68 4.40 18.11 3.9 <0.05
SOD (U/mg Hb) 2.98 0.59 3.13 0.89 <0.05
Ascorbic Acid (μmol/L) 44.69 27.06 71.88 20.65 <0.05
Retinol (μg/mL) 1.56 0.72 1.64 1.07 0.776
α tocopherol, (μg/mL) 13.90 4.59 20.68 4.18 <0.001
Lutein + Zeaxanthin (μmol/mL) 0.49 0.21 0.67 0.28 <0.05
β cryptoxanthin (μmol/mL) 0.44 0.50 0.97 0.83 <0.05
α Carotene (μmol/mL) 0.12 0.10 0.11 0.08 0.811
β Carotene (μmol/mL) 0.51 0.37 0.55 0.51 0.819
Lycopene (μmol/mL) 0.20 0.09 0.21 0.18 <0.05
Table 2: Antioxidant plasma levels in the elderly.
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Multiple regression analysis carried out to verify the impact of 
all the carotenoids, vitamins and antioxidant enzymes measured on 
MNA in the total sample, showed that only antioxidant vitamins were 
significantly correlated (R=0.75; p< 0.001). The same analysis carried 
out to verify the impact of the biochemical markers over reported 
on the MMSE in the total sample, showed that, also in this case, only 
antioxidant vitamins were significantly correlated ( R=0.73; p< 0.001).
Discussion
In our sample all the cases showed a worse nutritional status 
compared to controls, data confirmed by MNA scores as well as 
by anthropometric measurements: fifteen subjects were at risk of 
malnutrition while six subjects were frankly malnourished.
A comprehensive geriatric assessment including nutritional status 
is recommended in all the elderly population, at risk of malnutrition 
as reported by many authors [34-37], for a better care both in 
institutionalized and free living subjects. 
AD could result from an acceleration of the normal ageing 
process in brain regions particularly sensitive to free radical damage. 
Antioxidants could, therefore, play an important role in preventing the 
deleterious actions of free radicals in brains. Most of the antioxidants 
measured were lower in the AD patients compared to the controls. 
This may be partly due to the different nutritional status of the two 
groups and probably to the different dietary intake of the antioxidant 
nutrients. It would have been interesting to estimate dietary intakes 
of these nutrients, but there is not any valid method of dietary 
assessment specific for dement subjects unless the weighted method 
which is difficult to carry out. The absence of the antioxidants nutrition 
assessment in this sample is a study limit.
A large body of evidence shows that the risk of elderly subjects 
to develop AD increases every year; there are epidemiological studies 
showing a direct relationship between plasma antioxidant levels and 
cognitive performance [38] and between risk of cognitive decline and 
plasma levels of lipid peroxidation markers in humans [39].
In a study carried out by Rinaldi et al. [40], the modification 
of several components of the antioxidant defence system of the 
organism are shown both in MCI and AD subjects compared to 
healthy subjects. In this study the authors state that the antioxidant 
depletion is unlikely due to the presence of malnutrition, excluded 
by the thorough nutritional assessment performed in all subjects. In 
our study plasma levels of lutein plus zeaxanthin, beta-cryptoxanthin, 
lycopene, alfa tocopherol, ascorbic acid were significantly depleted in 
AD inpatients when compared to controls. This could be due to the 
presence of malnutrition as assessed in our AD group but even though 
studies support the hypothesis that subjects with AD are malnourished, 
particularly in the last phase of the disease, several recent researches 
demonstrate lower plasma antioxidant levels in the early AD stages also 
in well-nourished subjects [41,42].
In our study, the depleted levels of antioxidant vitamins in AD 
patients showed that the major components of the antioxidant defence 
system were affected in this condition. Antioxidants such as vitamin 
C play an important role in preventing the deleterious actions of free 
radicals in brains as well as a pathophysiological one in metal-mediated 
oxidative stress in AD [43]. Vitamin C is actively concentrated in the 
brain and is implicated in noradrenalin synthesis. Furthermore, this 
soluble antioxidant is considered to be the first barrier to free radicals 
produced in biological fluids, whereas vitamin E is a major element 
which breaks the peroxidation chain in membranes [44]. Its status is 
known to be inversely associated with cognitive performance in the 
elderly [45].
Although α and β Carotene did not differ in our sample, the 
antioxidant potential of carotenoids and retinol is gaining increasing 
attention with respect to dementing disorders [41,46]. 
AD patients in our study showed lower levels of lutein, zeaxanthin, 
β-cryptoxanthin and lycopene as compared to controls, in agreement 
with other studies reporting that these carotenoids seem to be efficient 
quenchers of singlet molecular oxygen and scavengers of peroxyl 
radicals [40,47].
The observed decrease in plasma levels of plasma SOD and GPx 
activities in AD patients in comparison to controls might be explained 
by a high free radical production occurring in this condition due to 
a rapid consumption of plasma antioxidants without a simultaneous 
activation of the antioxidant enzymes. Subjects developing AD may 
have a lower antioxidant enzymatic activity inadequate to counteract 
the hyper-production of free radicals during a condition of oxidative 
stress.
In conclusion the present study showed that plasma antioxidant 
levels and activities were decreased in AD. Although it was carried out 
on a small sample, the many antioxidant biomarkers tested suggested 
that the measurement of oxidative stress markers [46,48-50] could 
be used in the elderly in order to biologically predict an early mild 
cognitive decline evolving in AD. These measurements may be helpful 
to correct an antioxidant imbalance [51] and prevent or delay cognitive 
deterioration by means of diets containing high levels of antioxidants 
prior to the development of an AD.
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